HopeStage
Back to all studies
Active Not RecruitingNCT05698394

Esketamine for depression

This study is active but not recruiting in China. It is testing esketamine for depression.

Depression, KetamineDrugOver 18 Years
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
Changsha, China · Nanjing, China and 2 more locationsSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 9, 2023
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
364
Sponsor
Peking University First Hospital
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
China
Age range
Over 18 Years
Official registry ID
NCT05698394
Official title
Effect of Intravenous Low-dose Esketamine on Maternal Depression at 3 Years After Childbirth in Women With Prenatal Depression: 3-year Follow-up of a Randomized Controlled Trial

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT05698394. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Not recruiting

Changsha · Nanjing · Hangzhou

1 more locations
  • Beijing

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Peking University First Hospital, a university.

Does this study involve medication?

Yes. The study involves medication, including Esketamine and Placebo.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me